Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Rituximab Dosing and Immunoglobulin Replacement Therapy in Neuromyelitis Optica Spectrum Disorder: Results from an International Modified Delphi Panel Study

Author:Antonia Lefter  Tania Kumpfel  Jacqueline Palace  Zsolt Illes  Friedemann Paul  Georgina Arrambide  Orhan Aktas  Ayse Altintas  Thais Armangue  Gregor Brecl Jakob  Andrew Chan  Kumaran Deiva  Jelena Drulovic  Katrin Gross-Paju  Mario Habek  Maria Hastermann  Ellen Iacobaeus  Maciej Jurynczyk  Ming Lim  Sara Mariotto  Cecilia Rajda  Ernestina Santos  Aksel Siva  Romain Marignier  Paulus Rommer  Barbara Willekens  

Topic:Autoimmune Neurology  

Program Number:P1.004  

Author Institution:Ludwig Maximilian University of Munich, Munich, Germany  John Radcliff Hospital Oxford Univeristy Hospitals Trust, Oxford, United Kingdom  Odense University Hospital, University of Southern Denmark, Odense, Denmark  Charite Universitatsmedizin in Berlin, Berlin, Germany  Cemcat, Vall d´  Hebron University Hospital, BARCELONA, Spain  Neurologische Klinik, Dü  sseldorf, Germany  Koc University School of Medicine, Istanbul, Turkey  IDIBAPS-HClinic, Barcelona, Spain  University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia  Bern University Hospital, University of Bern, Bern, Switzerland  Bicê  tre Hospital, Assistance Publique-Hô  pitaux de Paris, Paris-Saclay University Hospitals, Le Kremlin-Bicê  tre, France  University Clinical Center of Serbia, Belgrade, Serbia  Laane-Tallinna Keskhaigla, Tallinn, Estonia  University Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia  Max Delbrueck Center for Molecular Medicine and Charité  -Universitä  tmedizin, Berlin, Germany  Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden  Institute of Psychiatry and Neurology, Warsaw, Poland  Evelina London Children`s Hospital at Guy`s and St Thomas` National Health Service Foundation Trust, London, United Kingdom  Neurology Unit, University of Verona, Verona, Italy  Department of Neurology, Faculty of Medicine, University of Szeged, 6725 Szeged, Hungary  Santo Antonio University Hospital Centre, University of Porto, Porto, Portugal  Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey  Lyon University Hospital, Lyon, France  AKH Wien / Univ. Klinik Fuer Neurologie, Vienna, Austria  Antwerp University Hospital, Edegem, Belgium  

Update on Phase 2 of KYSA-6, an Open-label, Single-arm, Multicenter Phase 2/3 Study of Miv-cel (Mivocabtagene Autoleucel; KYV-101), a Fully Human CD19 Chimeric Antigen Receptor (CAR) T-cell Therapy in Generalized Myasthenia Gravis (gMG)

Author:Marinos Dalakas  Srikanth Muppidi  Michael Hunter  Sarah Hoffmann  Tobias Hegelmaier  Jeremias Motte  Ralf Gold  Charlotte Schubert  Bradley Hunter     tter-Krö  Marie Luise nke  Christian Schultze-Florey  Roland Schroers  Francis Ayuk  Justin Chou  Xue Han  John Sun  Shouvonik Sengupta  Christine Bryant  Linus Sun  Dena Grayson  Naji Gehchan  Aiden Haghikia  

Topic:Autoimmune Neurology  

Program Number:P3.012  

Author Institution:Department of Neurology, Thomas Jefferson University, Philadelphia, PA  Department of Neurology, Stanford Healthcare, Stanford, CA  Department of Neuromuscular Medicine, Intermountain Medical Center, Murray, UT  Department of Neurology with Experimental Neurology and Neuroscience Clinical Research Center (NCRC), Charité  -Universitä  tsmedizin Berlin, 10117 Berlin, Germany  Department of Neurology with Clinical Neurophysiology, Hannover Medical School, Hannover, Germany  Department of Neurology, Ruhr University Bochum, Bochum, Germany  Institute of Neuroimmunology and Multiple Sclerosis and Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany  Department of Hematology Oncology, Blood and Marrow Transplantation, Intermountain LDS Hospital, Salt Lake City, UT  Department of Hematology, Oncology and Cancer Immunology, Charité  Universitä  tsmedizin Berlin, Berlin, Germany  Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany  Department of Hematology and Oncology, Ruhr University Bochum, Bochum, Germany  Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany  Kyverna Therapeutics, Inc., Emeryville, CA